Correspondence 0000950103-23-016653 from PROKIDNEY CORP. (PROK)

PROKIDNEY CORP.
Date: Nov. 28, 2023 · CIK: 0001850270 · Accession: 0000950103-23-016653

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-275701

Date

November 28, 2023

Author

Not clearly detected

Form

CORRESP

Company

PROKIDNEY CORP.

Letter

ProKidney Corp.

2000 Frontis Plaza Blvd.

Suite 250

Winston-Salem, NC

November 28, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E. Washington, D.C.

Attn: Jason Drory

Re: ProKidney Corp.

Registration Statement on Form S-3

File No. 333-275701

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, ProKidney Corp., a Cayman Islands exempted company (the “Registrant”), hereby requests acceleration of effectiveness of its registration statement on Form S-3 (File No. 333-275701), as amended, to 9:00 a.m. Eastern Time on November 30, 2023, or as soon as practicable thereafter.

The Registrant hereby authorizes Richard D. Truesdell, Jr of Davis Polk & Wardwell LLP to orally modify or withdraw this request for acceleration.

Please contact Richard D. Truesdell, Jr of Davis Polk & Wardwell LLP at (212) 450-4674 or richard.truesdell@davispolk.com with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.

Very truly yours,
PROKIDNEY CORP.

Show Raw Text

CORRESP
1
filename1.htm

ProKidney Corp.

2000 Frontis Plaza
Blvd.

Suite 250

Winston-Salem, NC
27103

November 28, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E. Washington, D.C.
20549

 Attn: Jason Drory

 Re: ProKidney
                                            Corp.

    Registration Statement on Form S-3

    File No. 333-275701

Ladies and Gentlemen:

Pursuant to Rule
461 under the Securities Act of 1933, as amended, ProKidney Corp., a Cayman Islands exempted company (the “Registrant”),
hereby requests acceleration of effectiveness of its registration statement on Form S-3 (File No. 333-275701), as amended, to 9:00 a.m. Eastern
Time on November 30, 2023, or as soon as practicable thereafter.

The Registrant
hereby authorizes Richard D. Truesdell, Jr of Davis Polk & Wardwell LLP to orally modify or withdraw this request for acceleration.

Please contact
Richard D. Truesdell, Jr of Davis Polk & Wardwell LLP at (212) 450-4674 or richard.truesdell@davispolk.com with any questions you
may have concerning this request, and please notify him when this request for acceleration has been granted.

    Very truly yours,

    PROKIDNEY CORP.

    By:
    /s/ James Coulston

    Name:
    James Coulston

    Title:
    Chief Financial Officer

[Signature Page to
Acceleration Request]

SecProbe.io